BriaCell Therapeutics Analyst Ratings
BriaCell Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest BriaCell Therapeutics (BCTX) rating was a reiterated with a price target of $0.00 to $25.00. The current price BriaCell Therapeutics (BCTX) is trading at is $7.21, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/24/2023 | 246.74% | HC Wainwright & Co. | → $25 | Reiterates | → Buy |
| 02/14/2022 | 246.74% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/24/2023 | 246.74% | HC 溫賴特 & 有限公司. | → 25 美元 | 重申 | → 購買 |
| 02/14/2022 | 246.74% | HC 溫賴特 & 有限公司. | → 25 美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for BriaCell Therapeutics (BCTX)?
百利賽爾治療（BCTX）的目標價格是多少？
The latest price target for BriaCell Therapeutics (NASDAQ: BCTX) was reported by HC Wainwright & Co. on February 24, 2023. The analyst firm set a price target for $25.00 expecting BCTX to rise to within 12 months (a possible 246.74% upside). 1 analyst firms have reported ratings in the last year.
碧雅賽爾治療學（納斯達克股票代碼：BCTX）的最新價格目標是由溫賴特有限公司於 2023 年 2 月 24 日報導。該分析師公司設定了 25.00 美元的價格目標，預計 BCTX 將在 12 個月內上升（可能是 246.74％ 的上行情況）。1 分析師公司在去年報告了評級。
What is the most recent analyst rating for BriaCell Therapeutics (BCTX)?
BriaCell 治療學（BCTX）的最新分析師評級是什麼？
The latest analyst rating for BriaCell Therapeutics (NASDAQ: BCTX) was provided by HC Wainwright & Co., and BriaCell Therapeutics reiterated their buy rating.
BriaCell 治療學（納斯達克：BCTX）的最新分析師評級由 HC 溫賴特公司提供，BriaCell 治療學重申了他們的購買評級。
When is the next analyst rating going to be posted or updated for BriaCell Therapeutics (BCTX)?
BriaCell 治療學（BCTX）的下一個分析師評級何時會發布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BriaCell Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BriaCell Therapeutics was filed on February 24, 2023 so you should expect the next rating to be made available sometime around February 24, 2024.
分析師在進行廣泛的研究後獲得了股票評級，其中包括通過公共財務報表，與 BriaCell Theraptics 的高管和客戶交談以及收聽盈利電話會議。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。BriaCell 治療的最後評級已於 2023 年 2 月 24 日提交，因此您應該期望下一個評級將在 2024 年 2 月 24 日左右提供。
Is the Analyst Rating BriaCell Therapeutics (BCTX) correct?
分析師評級 BriaCell 治療學（BCTX）是否正確？
While ratings are subjective and will change, the latest BriaCell Therapeutics (BCTX) rating was a reiterated with a price target of $0.00 to $25.00. The current price BriaCell Therapeutics (BCTX) is trading at is $7.21, which is within the analyst's predicted range.
儘管評級是主觀的並且會發生變化，但最新的 BACell 治療學（BCTX）評級重申，目標價格為 0.00 美元至 25.00 美元。目前的價格 BriaCell 治療（BCTX）的交易價格為 7.21 美元，這是在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
